Handelsbanken Fonder’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
B
NAMI
Handelsbanken Fonder's NEO Position: Q4 2025 in Review
Handelsbanken Fonder sold out of NeoGenomics (NEO) in Q4 2025, closing a stake of 28,300 shares — an estimated $218K sold.
Handelsbanken Fonder first reported a position in NEO in Q2 2020 and held it in 22 quarters. The position peaked at $1.18M in Q4 2020. 256 funds tracked by Wall St. Rank hold NEO as of Q4 2025.
- Handelsbanken Fonder reported no remaining NeoGenomics position as of Q4 2025 after selling out during the quarter.
- Handelsbanken Fonder sold 28,300 NeoGenomics shares in Q4 2025, an estimated $218K.
- Handelsbanken Fonder first reported a position in NeoGenomics in Q2 2020 and held it in 22 quarters.
- Handelsbanken Fonder's NeoGenomics position peaked at $1.18M in Q4 2020.
- 256 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2025.
Based on Handelsbanken Fonder's 13F filing for Q4 2025, filed 6 Feb 2026.